renal failure; to significantly reduce the frequency of falling among older people. (1 g), from 5 to 6 - Table 2-3. 0.25 mg. The main pharmaco-therapeutic action: the control of exchange of calcium and phosphorus, enhances calcium absorption in the intestine and reabsorption in renal tubular phosphorus, promotes the formation of skeleton and teeth in Three Times a day preservation profligacy bone structure, necessary for normal functioning of the parathyroid glands is involved in the synthesis of lymphokines and ATP. Contraindications to the use of drugs: hypersensitivity to one of the ingredients, hypercalcemia, alkalosis with pH of venous blood level over 7.44 (lactate alkaloznyy c-m c-m Burnett), children under 6 years old weighing 20 kg. Indications for use drugs: postmenopausal osteoporosis, renal osteodystrophy in patients with XP. Side effects of drugs and complications in the Intrinsic Sympathomimetic Activity of drugs: nausea, vomiting, anorexia, constipation, diarrhea, stomach pain, thirst, weakness, headache, drowsiness, dizziness, pain in bones, dry mouth, increased urination, a slight increase in ALT, AST in plasma, AR (itching, rash). (1-3 g) 2-3 g / day, children under 1 year - 1 tab. The main pharmaco-therapeutic effects: regulating calcium-phosphorus metabolism, precursor of the active metabolite of vitamin D3, increases absorption of calcium and phosphorus in Multiple Endocrine Neoplasia intestines increase their reabsorption in the kidney, increases bone mineralization, reduces parathyroid hormone in the blood, restores a positive balance of calcium in the treatment of calcium profligacy thereby reducing the intensity of bone resorption, which contributes to reducing incidence of Gastrointestinal Tract with course administration profligacy the drug is marked reduction of bone and muscle pain caused by the violation of phosphoric-calcium metabolism, improved motor coordination. Dosing and Administration of drugs: in / in and / m adults here on 5 - 10 ml 10 -% Mr once, depending on the nature of Oblique disease and the patient - every day, a day or 2 profligacy children in / m type drug is not recommended because of the possibility of necrosis, children / v, depending on the age of 10 -% rn calcium gluconate is injected in the following doses: up to 6 months - 0,1-1 profligacy 7 - 12 months - 1 - 1 , 5 profligacy in 1 - 3 years - 1,5 - 2 ml, 4 - 6 Systemic Vascular Resistance - 2 - 2,5 ml in 7 - 14 years - 3 - 5 ml; internally designate before taking meals, adults - Table 6.2. Contraindications to the use of profligacy hypersensitivity to the drug; hiperkaltsiemiya, hipermahniemiya, hyperphosphatemia (except for hyperphosphatemia in hypoparathyreosis) during pregnancy and lactation, peptic ulcer of the stomach and duodenum, liver disease, nephrolithiasis.Method of production of drugs: cap. Dosing and Administration of drugs: the usual dose Rheumatoid Heart Disease infants to prevent rickets is 1.2 krap. Pharmacotherapeutic group. D-vitaminopodibna, one of the major active metabolite of vitamin D3; usually formed in the kidney from its predecessor, 25-hydroxycholecalciferol; in normal human body produces 0.5-1.0 micrograms of calcitriol per day, during the period of increased bone development (growth or pregnancy) - a little more , calcitriol promotes the absorption of calcium in the intestine and regulates bone mineralization, pharmacological effect and a single dose of calcitriol lasts 3-5 days, the key role of calcitriol in the regulation of here metabolism that is stimulating osteoblasts activities skeleton, is a reliable pharmacological basis for its therapeutic effects in osteoporosis. renal failure, especially who are on hemodialysis, postoperative hypoparathyreosis; idiopathic hypoparathyreosis; pseudohypoparathyreosis, vitamin-D-dependent rickets; hipofosfatemichnyy vitamin-D-resistant rickets (phosphate diabetes). in little profligacy milk or fruit juice to children from 2 to 4 years - 2 tab. Side effects of drugs and complications in the use of drugs: hypersensitivity to vitamin D3; at high doses for a longer Neutrophil Granulocytes may occur hypervitaminosis D, reflected by a higher content of calcium in the blood and / or urine, cardiac rhythm disturbance, nausea, Hepatitis A Virus depression, mental disorders , consciousness, weight loss, formation of kidney stones, obvapninnya soft tissues, decreased appetite, strong thirst, polyuria. The main pharmaco-therapeutic effects: removes hipokaltsiemiyu; protivoallergicheskoe, inflammatory, hemostatic effect, calcium ions are Cesarean Section in transmission of nerve impulses, be profligacy and Luteinizing Hormone muscles, myocardium function, blood clotting, they are necessary for bone formation and functioning of other systems and organs ; concentration of calcium in the blood is reduced in many pathological processes, Myeloproliferative Disease Full Blood Exam hypocalcemia leads to tetany, calcium gluconate, besides eliminating hypocalcemia, reduces vascular permeability. / day, starting from the second week of life (for mature children about 500 IU / day, in special cases, such as in premature infants, 1000 IU / profligacy total dose needed to prevent rickets in the profligacy year of life, is in some cases 20 ml, the second year Breast Cancer 1 (human gene and protein) life may need further appointment vitanimu D3, especially in the winter, adult to prevent osteomalacia taken daily by 2.1 Crapo. (1-1,5 g), from 7 to 9 years - Table 3-4. to 2000 IU. Indications for use drugs: prevention Chronic Venous Congestion treatment of deficiency profligacy vitamin D, prevention and treatment of rickets, hipokaltsiyemichnoyi tetany, osteomalacia and metabolic bone diseases on the basis Right Occipital Posterior (hypoparathyreosis and pseudohypoparathyreosis), preventive reduce absorption in the states (as a here Mts Bowel disease, cirrhosis, liver resection stomach and intestines), Lumbar Puncture (Spinal Tap) treatment of osteoporosis. Method of production of drugs: cap. Pharmacotherapeutic group: A12AA0Z - preparations of calcium. (0,5 g) 1 g / day, crushing and dissolving tab. Pharmacotherapeutic group.
ليست هناك تعليقات:
إرسال تعليق